Globus Medical Announces FDA 510(k) Clearance for Excelsius GPS™

AUDUBON, Pa., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading ...

Abiomed Surpasses 50,000 Impella® Patients Treated in the United States

DANVERS, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider ...

Abiomed Surpasses 50,000 Impella® Patients Treated in the United States

DANVERS, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider ...

Globus Medical Announces CE Mark for Excelsius GPS™

AUDUBON, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading ...